In Belgium, the responsibilities for research are divided between Belgium’s Communities and the federal state. The budget for scientific research in the drugs field is provided under the Federal Drug Policy Note, and is managed by the Belgian Federal Science Policy Office (BELSPO) through a research programme that supports federal policy. Most studies that are funded through this programme are carried out by networks of researchers. The national focal point for the EMCDDA collects information on ongoing and completed studies in Belgium and disseminates information on drug-related research findings to audiences through a variety of channels.
Recent drug-related research in Belgium mainly includes population-based and clinical studies of epidemiology and treatment interventions. National scientific journals in Belgium publish drug-related research.